See other videos & webinars
CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention
In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
To view the webinar, please complete the form, or
sign in to your account.
I agree to receive future electronic communications from STEMCELL. I acknowledge that I can unsubscribe any time.
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our
with any questions that you may have. You can unsubscribe or change your
at any time.